WITH the holiday season rapidly approaching and COVID-19 still present in the community, now is a good time for pharmacists to remind Australians at higher risk of serious illness to take proactive steps to protect their health.
These steps can include advice about preventative measures, testing, steps patients should take if they experience symptoms, and eligibility for antivirals.
A PCR test is no longer necessary in order for eligible patients to access antivirals, and a positive RAT will suffice (PD 03 Dec).
Results from the fifth COVID Community Sentiment Index, commissioned by Pfizer Australia in Nov 2024, reveal that more than 90% of Australians are putting COVID-safe behaviours on the backburner as they gear up for summer holiday travel.
The figure was similar among those at higher risk of serious illness from COVID.
Less than half (42%) of the 1,000 people surveyed said they would test for COVID if symptomatic, and 19% said they would still go out in public if they tested positive.
While almost two-thirds of high-risk patients were concerned about personal risk, only a third had developed a COVID action plan with their doctor and fewer than a third planned to familiarise themselves with local health services at their holiday destination.
However, for high-risk patients who test positive, early action can help reduce the severity of COVID.
Dr Krishan Thiru, Medical Director at Pfizer Australia and New Zealand noted that at this time of year there is typically a rise in COVID cases.
"For patients at higher risk of serious illness, prompt action can mean the difference between mild illness and severe complications.
"Early discussions with patients about testing, eligibility for oral antivirals and planning for potential exposure are key steps ahead of the summer holiday season," he said. KB
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 24
